THERATECHNOLOGIES INC (TH.CA) Stock Overview
TSX:TH - CA88338H7040 - Common Stock
TH.CA Key Statistics, Chart & Performance
The current stock price of TH.CA is 4.59 CAD. In the past month the price increased by 3.85%. In the past year, price increased by 149.46%.
TH.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 494.47M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 353.72M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 267.54M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 114.57M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 94.42M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 86.75M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 82.42M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 68.23M | ||
| NRX.CA | NUREXONE BIOLOGIC INC | N/A | 68.01M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 17.46 | 62.24M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 48.52M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 32.21M |
Related stock screener links
About TH.CA
Company Profile
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The company is headquartered in Montreal, Quebec and currently employs 94 full-time employees. The firm offers prescription products for individuals with human immunodeficient virus (HIV) in the United States and its pipeline is focused on specialized therapies designed to address unmet medical needs in both HIV and oncology. The company markets two HIV products, namely EGRIFTA SV and Trogarzo; and has research programs in HIV and oncology. EGRIFTA SV is the therapy for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. Trogarzo injection is used with other antiretrovirals to treat HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 who are failing their current regimen. Its pipeline includes Donidalorsen and Olezarsen, and the SORT1+ oncology platform. The firm is also focusing on tesamorelin life-cycle management in lipodystrophy.
Company Info
THERATECHNOLOGIES INC
2015 Peel Street, 11th Floor
MONTREAL QUEBEC H3A 1T8 CA
CEO: Paul Levesque
Employees: 103
Phone: 15143367800
THERATECHNOLOGIES INC / TH.CA FAQ
What is the stock price of THERATECHNOLOGIES INC today?
The current stock price of TH.CA is 4.59 CAD. The price increased by 0.88% in the last trading session.
What is the ticker symbol for THERATECHNOLOGIES INC stock?
The exchange symbol of THERATECHNOLOGIES INC is TH and it is listed on the Toronto Stock Exchange exchange.
On which exchange is TH.CA stock listed?
TH.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for THERATECHNOLOGIES INC stock?
10 analysts have analysed TH.CA and the average price target is 5.64 CAD. This implies a price increase of 22.78% is expected in the next year compared to the current price of 4.59. Check the THERATECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is THERATECHNOLOGIES INC worth?
THERATECHNOLOGIES INC (TH.CA) has a market capitalization of 211.05M CAD. This makes TH.CA a Micro Cap stock.
How many employees does THERATECHNOLOGIES INC have?
THERATECHNOLOGIES INC (TH.CA) currently has 103 employees.
What are the support and resistance levels for THERATECHNOLOGIES INC (TH.CA) stock?
THERATECHNOLOGIES INC (TH.CA) has a support level at 4.5 and a resistance level at 4.6. Check the full technical report for a detailed analysis of TH.CA support and resistance levels.
Is THERATECHNOLOGIES INC (TH.CA) expected to grow?
The Revenue of THERATECHNOLOGIES INC (TH.CA) is expected to decline by -3.03% in the next year. Check the estimates tab for more information on the TH.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy THERATECHNOLOGIES INC (TH.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TH.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TH.CA, evaluating the profitability, health, valuation and growth aspects
- THERATECHNOLOGIES INC (TH.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- THERATECHNOLOGIES INC (TH.CA) Sales and EPS estimates to see what analysts future expectations are.
- THERATECHNOLOGIES INC (TH.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- THERATECHNOLOGIES INC (TH.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- THERATECHNOLOGIES INC (TH.CA) Stock Chart to make your own analysis
- THERATECHNOLOGIES INC (TH.CA) Latest news and press-releases to stay up to date.
Does THERATECHNOLOGIES INC (TH.CA) stock pay dividends?
TH.CA does not pay a dividend.
When does THERATECHNOLOGIES INC (TH.CA) report earnings?
THERATECHNOLOGIES INC (TH.CA) will report earnings on 2025-10-08, before the market open.
What is the Price/Earnings (PE) ratio of THERATECHNOLOGIES INC (TH.CA)?
THERATECHNOLOGIES INC (TH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.26).
TH.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to TH.CA. When comparing the yearly performance of all stocks, TH.CA is one of the better performing stocks in the market, outperforming 92.22% of all stocks.
TH.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TH.CA. While TH.CA is still in line with the averages on profitability rating, there are concerns on its financial health.
TH.CA Financial Highlights
Over the last trailing twelve months TH.CA reported a non-GAAP Earnings per Share(EPS) of -0.26.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TH.CA Forecast & Estimates
10 analysts have analysed TH.CA and the average price target is 5.64 CAD. This implies a price increase of 22.78% is expected in the next year compared to the current price of 4.59.
For the next year, analysts expect an EPS growth of 88.56% and a revenue growth -3.03% for TH.CA